Recurrent vulvovaginitis: Diagnostic assessment and therapeutic management;Vulvovaginitis de repetición. Valoración diagnóstica y manejo terapéutico

Actas Dermo-Sifiliograficas

Volumn 99, Issue 3, 2008, Pages 190-198

  Ramirez Santos A ^a   Pereiro Jr , Manuel ^a,b   Toribio, J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Allergic vulvovaginitis; Bacterial vaginosis; Trichomonas; Vulvovaginal candidosis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHISTAMINIC AGENT; ASTEMIZOLE; BICARBONATE; BUTOCONAZOLE; CISAPRIDE; CLINDAMYCIN; CLOTRIMAZOLE; DOXYCYCLINE; ECONAZOLE; ESTROGEN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; METRONIDAZOLE; MICONAZOLE; NITROIMIDAZOLE; NYSTATIN; PAROMOMYCIN; PYRROLE DERIVATIVE; TERCONAZOLE; TINIDAZOLE; TIOCONAZOLE;

ALGORITHM; ALLERGIC VULVOVAGINITIS; BEDTIME DOSAGE; CANDIDA ALBICANS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; FEMALE; GARDNERELLA VAGINALIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; RECURRENT DISEASE; REVIEW; TASTE DISORDER; TRICHOMONAS; VAGINA ATROPHY; VAGINA CANDIDIASIS; VAGINITIS; VULVOVAGINITIS;

EID: 41949100543     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(08)70231-2     Document Type: Article

References (65)

1. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol. 1991;165:1168-76.
2. Quan M. Vaginitis: meeting the clinical challenge. Clin Cornerstone. 2000;3:36-47.
3. Nyirjesy P. Chronic vulvovaginal candidiasis. Am Fam Physician. 2001;63:697-702.
4. Mulley AG. Approach to the patient with a vaginal discharge. En: Goroll AH, Mulley AG, editors. Primary care medicine: Office Evaluation and Management of the adult patient. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 702-7.
5. Mitchell H. ABC of sexually transmitted infections. Vaginal discharge-causes, diagnosis and treatment. BMJ. 2004;328:1306-8.
6. Say PJ, Jachyntho C. Difficult-to-Manage Vaginitis. Clin Obstet Gynecol. 2005;48:753-68.
7. duBouchet L, McGregor JA, Ismail M, McCormack WM. A pilot study of metronidazole vagina gel versus oral metronidzol for the treatment of Trichomonas vaginalis vaginitis. Sex Transm Dis. 1998;25:176-9.
8. Eckert LO. Acute vulvovaginitis. N Eng J Med. 2006;21:1244-52.
9. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole resistant vaginal trichomoniasis. Clin Infect Dis. 2001;33:1341-6.
10. Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Gelone SP. Difficult-to-treat trichomoniasis: results with paromomycin cream. Clin Infect Dis. 1998;26:986-8.
11. Patlman RS. Recalcitrant vaginal trichomoniasis. Sex Transm Infect. 1999;75:127-8.
12. Sexually transmitted diseases treatment guidelines 2006. Centres for Disease Control and Prevention MMWR Recomm Rep 2006; 55/RR11:49-56. (Consultado: 20-06-2007): Disponible en: http://www.cdc.gov/std/treatment/2006/rr5511.pdf.
13. Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis. 1999;28 Suppl 1:57-65.
14. Sobel JD. Bacterial vaginosis. Annu Rev Med. 2000;51:349-56.
15. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, et al. Suppressive antibacterial therapy with 0,75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194:1283-9.
16. French L, Horton J, Matousek M. Abnormal vaginal discharge: what does and does notwork in treating underlying causes. J Fam Pract. 2004;53:890-4.
17. Edwards L. The diagnosis and treatment of infectious vaginitis. Dermatol Ther. 2004;17:102-10.
18. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect. 2004;80:8-11.
19. McCormack WM Jr, Zinder SH, Mc Cormack WM. The incidente of genitourinary infections in a cohort of healthy women. Sex Transm Dis. 1994;21:63-4.
20. Sobel JD. Vulvovaginal candidosis. The Lancet. 2007;369:1961-71.
21. Giraldo P, Von Nowaskonski A, Gomes FA, Lindares I, Neves NA, Witkin SS. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal Candidiasis. Obstet Gynecol. 2000;95:413-6.
22. Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med. 1998;13:335-46.
23. Ferrer J. Vaginal candidosis: epidemiologic and etiological factors. Int J Gynaecol Obstet. 2000;71 Suppl 1:21-7.
24. Hillier S, Sobel J. Vaginal infections. En: Morse SA, Ballard RC, editors. Atlas of sexually transmitted diseases&AIDS. St Louis: Mosby; 2003. p. 159-79.
25. Ringdahl EN. Treatment of recurrent vulvovaginal candidiasis. Am Fam Physician. 2000;61:3317.
26. Fidel PL Jr. History and update on host defense against vaginal candidiasis. Am J Reproductive Immunol. 2006;57:2-12.
27. Spacek J, Buchta V. Itraconazole in the treatment of acute and recurrent vulvovaginal candidiasis: Comparison of a 1-day and a 3-day regimen. Mycoses. 2005;48:165-71.
28. Nyirjesy P, Seeney SM, Grody MH, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol. 1995;173:820-3.
29. Ritcher SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiologic of recurrent cases. J Clin Microbiol. 2005;43:2155-62.
30. Holland J, Young ML, Lee O, Chen CA. Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect. 2003;79:249-50.
31. Spinillo A, Capuzzo E, Gulminetti R, Marone P, Colonna l, Piazzi G. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol. 1997;176:138-41.
32. Miles MR, Olsen L, Rogers A. Recurrent vaginal candidiasis. Important of an intestinal reservoir. JAMA. 1977;238:1836-7.
33. Fong IW. The rectal carriage of yeast in patients with vaginal candidiasis. Clin Invest Med. 1994;17:426-31.
34. Schmid J, Rotman M, Reed B, Pierson CL, Soll DR. Genetic similarity of candida albicans strains from vaginitis patients and their partners. J Clin Microbiol. 1993;31:39-46.
35. Vázquez JA, Sobel JD, Demitriou R, Vaishampayan J, Lynch M, Zervos MJ. Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis. 1994;170:1566-9.
36. Magliani W, Conti S, Cassone A, De Bernardis F, Polonelli L. New immunotherapic strategies to control vaginal Candidiasis. Trends Mol Med. 2002;8:121-5.
37. Spacek J, Jilek P, Buchta V, Förstl M, Hronek M, Holeckova M. The serum levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal candidosis during attack, remission and in healthy controls. Mycoses. 2005;48:391-5.
38. Owen MK, Clenney TL. Management of vaginitis. Am Fam Physician. 2004;70:2125-32.
39. Erdem A, Cetil M, Timuroglu T, Cetil A, Yanar O, Pahsa A. Identification of yeasts in public hospital primary care patients with or without clinical vaginitis. Aust N Z J Obstet Gynaecol. 2003;43:312-6.
40. de León EM, Jacober SJ, Sobel JD, Forman B. Prevalence and risk factors for vaginal candida colonization in women with type 1 and type 2 diabetes. BMJ Infect Dis. 2002;2:1-4.
41. Donders GG, Prenen H, Verveke G, Reybrouk R. Impaired tolerance for glucose in women with recurrent vaginal candidosis. Am J Obstet Gynecol. 2002;187:989-93.
42. Bluestein D, Rutledge C, Lumsden L. Predicting the ocurrente of antibiotic-induced candidal vaginitis. Fam Pract Res. 2001;11:319-26.
43. Galask RP. Vaginal colonization by bacteria and yeast. Am J Obstet Gynecol. 1988;158:993-5.
44. Hellberg D, Zdolsek B, Nilsson S, Mardh PA. Sexual behavior of women with repeated episodes of vulvovaginal Candiasis. Eur J Epidemiol. 1995;11:575-9.
45. Goplerud C, Ohm M, Galask R. Aerobic and anaerobic flora of the cervix during pregnancy and the puerperium. Am J Obstet Gynecol. 1976;126:858-68.
46. Neves NA, Ábralo LP, De Oliveira MAM, Giraldo PC, Bacellar O, Cruz AA, et al. Association between atopy and recurrent vaginal candidiasis. Clin Exp Immunol. 2005;142:167-71.
47. Rhoads JL, Wright DC, Redfield RR, Burke DS. Chronic vaginal candidosis in women with human immunodeficiency virus infection. JAMA. 1987;257:3105-7.
48. Fidel PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev. 1996;9:335-48.
49. Ventolini G, Baggish M. Post-menopausal recurrent vaginal candidiasis: effect of histerectomy on response to treatment, type of colonization and recurrence rates post-treatment. Maturitas. 2005;51:294-8.
50. Goldacre MJ, Watt B, Loudon N, Milne LJ, Loudon JD, Vessey MP. Vaginal microbial flora in normal young women. BMJ. 1979;1:1450-5.
51. Marazzo J. Vulvovaginal candidiasis. BMJ. 2002;325:586-7.
52. Reef SE, Levine WC, McNeil MM, Fisher-Hoch S, Holmberg SD, Duerr A, et al. Treatment options for vulvovaginal Candidiasis, 1993. Clin Infect Dis. 1995;20 Suppl 1:80-90.
53. Sobel JD. Vulvovaginitis. When Candida becomes a problem. Dermatol Clin. 1998;16:763-8.
54. Williams AB. Ginecologic care for women with HIV infection. JOGNN. 2003;32:87-93.
55. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis. Epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998;178:203-11.
56. Fong IW. The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketokonazole. Geenitourin Med. 1992;6:174-6.
57. Cross EW, Park S, Perlin DS. Cross-resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis. Microb Drug Resist. 2000;6:155-61.
58. Sobel JD, Chaim W, Nagappan V, Leaman D. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol. 2003;189:1297-300.
59. White DJ, Vanthuyme A. Vulvovaginal candidiasis. Sex Transm Infect. 2006;82 Suppl 4:28-30.
60. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal Candidiasis: a review. J Antimicrob Chemother. 2006;58:266-72.
61. Cibley LJ, Cibley LJ. Cytolytic vaginosis. Am J Obstet Gynecol. 1991;165:1245-9.
62. Horowitz BJ, Mardl PA, Nagy E, Rank EL. Vaginal lactobacillosis. Am J Obstet Gynecol. 1994;170:857-61.
63. Moraes PS, Taketomi EA. Allergic vulvovaginitis. Ann Allergy Asthma Immunol. 2000;85: 253-65.
64. Ramírez de Knott HM, McCormick TS, Oshtory Do S, Goodman W, Ghannoum MA, Cooper KV, et al. Cutaneous hypersensitivity to Candida Albicans in idiopathic vulvodynia. Contact Dermatitis. 2005;53:214-8.
65. Marren P, Wojnarowska F, Powell S. Allergic contact dermatitis and vulvar dermatoses. Br J Dermatol. 1992;126:52-6.